ICON Public Limited Company ICON Public Limited Company

ICON Public Limited Company

ICLR

Rankning i aktier #1654
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Aktiekurs
$168.25
Senast synkroniserad: 2026-10-16
Marknadsvärde
$12.98B
Förändring (1 dag)
-3.93%
Förändring (1 år)
-9.08%
Land
IE
Handel ICON Public Limited Company (ICLR)

Kategori

Healthcare
Rörelsemarginal för ICON Public Limited Company (ICLR)
Rörelsemarginal per October 2026 TTM: 10.15%
Enligt de senaste finansiella rapporterna och aktiekursen för ICON Public Limited Company är företagets nuvarande rörelsemarginal (TTM) 10.15%. Vid slutet av 2023 var rörelsemarginalen 11.78%.
Historik för rörelsemarginal för ICON Public Limited Company från 2001 till 2026
Rörelsemarginal vid slutet av varje år
År Rörelsemarginal Ändra
2026 (TTM) 10.15% -23.45%
2024 13.26% 12.56%
2023 11.78% 14.70%
2022 10.27% 48.63%
2021 6.91% -50.64%
2020 14.00% -9.39%
2019 15.45% 7.44%
2018 14.38% -25.26%
2017 19.24% 2.89%
2016 18.70% 4.59%
2015 17.88% 32.84%
2014 13.46% 48.40%
2013 9.07% 39.54%
2012 6.50% 56.63%
2011 4.15% -59.43%
2010 10.23% -15.52%
2009 12.11% 5.30%
2008 11.50% 4.74%
2007 10.98% 4.57%
2006 10.50% 83.57%
2005 5.72% -50.60%
2004 11.58% 4.89%
2003 11.04% -5.07%
2002 11.63% 22.04%
2001 9.53% 0.00%
Rörelsemarginal för liknande företag eller konkurrenter
Företag Rörelsemarginal Skillnad i rörelsemarginal Land
17.97% -98.23%
US
20.42% -97.99%
US
-10.70% -101.05%
US
0.00% -
CN
22.23% -97.81%
US
Vad är ett företags Rörelsemarginal?
Rörelsemarginal är en viktig indikator för att bedöma ett företags lönsamhet. Högre Rörelsemarginals är generellt bättre eftersom de visar att ett företag kan sälja sina produkter eller tjänster för betydligt mer än produktionskostnaden. Rörelsemarginal beräknas genom att dividera företagets vinst med dess intäkter.